newsfilter
← Interviews
a16z29 min

a16z Podcast | Taking the Pulse on Bio

Jorge Conde, Vijay Pande, Malinka Walaliyadde, Jeffrey Low, Hannah

Podcast, Interview

A16Z is shifting its bio-investment thesis from empirical science to engineered biology, prioritizing ventures where established biological mechanisms allow founders to apply AI and data-driven engineering to de-risk development. This approach targets sectors like diagnostic genomics and cell therapies, leveraging network effects and reusable platforms to transform unpredictable research into scalable, schedulable manufacturing processes. By favoring hybrid founders with expertise in both computer science and biology, the firm aims to accelerate innovation cycles and capture value in an era where technical execution supersedes novel biological discovery.